Document is current
Any future updates will be listed below
-
Authors
Feber, Lena http://orcid.org/0000-0002-4094-7579
Peter, Natalie http://orcid.org/0000-0002-5058-3270
Schneider-Thoma, Johannes
Siafis, Spyridon
Bighelli, Irene
Hansen, Wulf-Peter
Prates Baldez, Daniel
Salanti, Georgia
Keefe, Richard S. E.
Engel, Rolf R.
Leucht, Stefan
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KG2108)
Technische Universität München
- License Information
-
More Information
Article History
Received: 24 August 2022
Accepted: 6 March 2023
First Online: 24 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: SL has received honoraria as a consultant and/or advisor and/or for lectures from Alkermes, Angelini, Eisai, Gedeon Richter, Janssen, Lundbeck, Lundbeck Institute, Merck Sharp and Dohme, Otsuka, Recordati, Rovi, Sanofi Aventis, TEVA, Medichem, and Mitsubishi. RSEK is a consultant of WCG, Merck, Sunovion, Karuna, Boehringer-Ingelheim, and Biogen. RSEK receives royalties from the Brief Assessment of Cognition in Schizophrenia (BACS). The other authors declare that they have no competing interests.
